Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Model to Predict Cause-Specific Mortality in Patients with Head and Neck Adenoid Cystic Carcinoma: A Competing Risk Analysis.

Imanguli M, Sumer BD.

Ann Surg Oncol. 2017 Aug;24(8):2069-2070. doi: 10.1245/s10434-017-5862-y. Epub 2017 May 26. No abstract available.

PMID:
28550487
2.

Risk factors for residual obstructive sleep apnea after adenotonsillectomy in children.

Imanguli M, Ulualp SO.

Laryngoscope. 2016 Nov;126(11):2624-2629. doi: 10.1002/lary.25979. Epub 2016 Mar 24.

PMID:
27010662
3.

Upregulation of IFN-Inducible and Damage-Response Pathways in Chronic Graft-versus-Host Disease.

Hakim FT, Memon S, Jin P, Imanguli MM, Wang H, Rehman N, Yan XY, Rose J, Mays JW, Dhamala S, Kapoor V, Telford W, Dickinson J, Davis S, Halverson D, Naik HB, Baird K, Fowler D, Stroncek D, Cowen EW, Pavletic SZ, Gress RE.

J Immunol. 2016 Nov 1;197(9):3490-3503. Epub 2016 Sep 30.

4.

Erratum to "Salivary Gland Involvement in Chronic Graft-versus-Host Disease: Prevalence, Clinical Significance, and Recommendations for Evaluation" [Biol Blood Marrow Transplant 16:1362-1369].

Imanguli MM, Atkinson JC, Mitchell SA, Avila DN, Bishop RJ, Cowen EW, Datiles MB, Hakim FT, Kleiner DE, Krumlauf MC, Pavletic SZ.

Biol Blood Marrow Transplant. 2016 Jun;22(6):1147. doi: 10.1016/j.bbmt.2015.09.026. Epub 2015 Oct 9. No abstract available.

5.

Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes.

Keck MK, Zuo Z, Khattri A, Stricker TP, Brown CD, Imanguli M, Rieke D, Endhardt K, Fang P, Br├Ągelmann J, DeBoer R, El-Dinali M, Aktolga S, Lei Z, Tan P, Rozen SG, Salgia R, Weichselbaum RR, Lingen MW, Story MD, Ang KK, Cohen EE, White KP, Vokes EE, Seiwert TY.

Clin Cancer Res. 2015 Feb 15;21(4):870-81. doi: 10.1158/1078-0432.CCR-14-2481. Epub 2014 Dec 9.

6.

Comparative analysis of FoxP3(+) regulatory T cells in the target tissues and blood in chronic graft versus host disease.

Imanguli MM, Cowen EW, Rose J, Dhamala S, Swaim W, Lafond S, Yagi B, Gress RE, Pavletic SZ, Hakim FT.

Leukemia. 2014 Oct;28(10):2016-27. doi: 10.1038/leu.2014.92. Epub 2014 Feb 28.

PMID:
24577531
7.

A multicenter pilot evaluation of the National Institutes of Health chronic graft-versus-host disease (cGVHD) therapeutic response measures: feasibility, interrater reliability, and minimum detectable change.

Mitchell SA, Jacobsohn D, Thormann Powers KE, Carpenter PA, Flowers ME, Cowen EW, Schubert M, Turner ML, Lee SJ, Martin P, Bishop MR, Baird K, Bola├▒os-Meade J, Boyd K, Fall-Dickson JM, Gerber LH, Guadagnini JP, Imanguli M, Krumlauf MC, Lawley L, Li L, Reeve BB, Clayton JA, Vogelsang GB, Pavletic SZ.

Biol Blood Marrow Transplant. 2011 Nov;17(11):1619-29. doi: 10.1016/j.bbmt.2011.04.002. Epub 2011 Apr 12.

8.

Salivary gland involvement in chronic graft-versus-host disease: prevalence, clinical significance, and recommendations for evaluation.

Imanguli MM, Atkinson JC, Mitchell SA, Avila DN, Bishop RJ, Cowen EW, Datiles MB, Hakim FT, Kleiner DE, Krumlauf MC, Pavletic SZ.

Biol Blood Marrow Transplant. 2010 Oct;16(10):1362-9. doi: 10.1016/j.bbmt.2010.03.023. Epub 2010 Mar 28. Erratum in: Biol Blood Marrow Transplant. 2016 Jun;22(6):1147.

9.

Increased T-bet+ cytotoxic effectors and type I interferon-mediated processes in chronic graft-versus-host disease of the oral mucosa.

Imanguli MM, Swaim WD, League SC, Gress RE, Pavletic SZ, Hakim FT.

Blood. 2009 Apr 9;113(15):3620-30. doi: 10.1182/blood-2008-07-168351. Epub 2009 Jan 23.

10.

Oral graft-versus-host disease.

Imanguli MM, Alevizos I, Brown R, Pavletic SZ, Atkinson JC.

Oral Dis. 2008 Jul;14(5):396-412. doi: 10.1111/j.1601-0825.2008.01448.x. Review.

11.

Myofibroblastic tumor of the lower lip in a patient with X-linked hypogammaglobulinemia and isolated growth hormone deficiency: a case report.

Imanguli MM, Karai LJ, Shanti RM, Stewart DM, Brahim JS.

J Oral Maxillofac Surg. 2007 Jun;65(6):1219-22. No abstract available.

PMID:
17517309
12.

Changes in salivary proteome following allogeneic hematopoietic stem cell transplantation.

Imanguli MM, Atkinson JC, Harvey KE, Hoehn GT, Ryu OH, Wu T, Kingman A, Barrett AJ, Bishop MR, Childs RW, Fowler DH, Pavletic SZ, Hart TC.

Exp Hematol. 2007 Feb;35(2):184-92.

13.

Chronic graft versus host disease of oral mucosa: review of available therapies.

Imanguli MM, Pavletic SZ, Guadagnini JP, Brahim JS, Atkinson JC.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Feb;101(2):175-83. Review.

PMID:
16448918

Supplemental Content

Loading ...
Support Center